Microsoft Word - MD฿A ประจำปี 2560_E 1 -1- Management Discussion and Analysis for the Year 2017 1. Operating Results (Company and Subsidiaries) Consolidated revenue for the twelve months of year 2017

.... Risk Disclosure Statement for Futures and Options Trading in Derivatives Exchange Date……………………………… We,……………[company name]………….…,who are a derivatives agent, hereby certify that Mr/Miss/Mrs

Electronics PCL has the pleasure of submitting third quarter of 2017 operating results of the Company and its subsidiaries ("the Group") based on reviewed consolidated financial statements for the three-month

, totally baht 451,000,000. Detail of the transactions are as follows : 1. Transaction date With in September 2nd, 2019. 2. Parties involved Buyer : Ramkhamhaeng Hospital Public Co.,Ltd. Seller : Buy Share in

was always higher than its acquisition price. The buy side would occur in the opposite direction. Instead of buying securities for UBS?s clients at the best offer available on the SET main board

สิ้นสุดระยะเวลารับซื้อ   Listed Company แบบรายงาน หลักทรัพย์ ชื่อผู้ได้มา/จำหน่าย 2 sell/buy/เพิ่ม-ลด concert party/เพิ่ม-ลด ม.258 ประเภท หลักทรัพย์ 1 %ได้มา/ จำหน่าย 2 %หลังได้มา/ จำหน่าย 2 วันที่ได้มา

2,839.1 67.0 Total Operating Expenses 6,532.6 3,887.7 2,644.9 68.0 Profit (Loss) 392.1 236.8 155.3 65.6 For the Company’s performance in 2019, the Company had achieved the highest total revenue since the

margin decreased by 3 percentage points to 7% in 2019 from 10% in 2018. SGA expenses decreased by 2% [THB 19m] due to reduced SGA expense at the Jiaxing plant. Payout Analysis For the year 2019 the company

million]. Payout Analysis For the year 2017 the company paid an interim dividend of THB 805 million in Q4/17. For the year 2016 the company paid full dividends of THB 1,610 million (THB 2.00/share). An

contract to buy and to sell such shares that ECF-P holds 33.37 percent. However, after the Company concludes evidently the source of funding to purchase shares from the buyer, the Company will comply with to